Capitalizing on this background and consistent with the positive correlation of PD-1 expression with CD8 and PD-L1 expression as shown in our study, patients with TMIT I tumours can represent a stronger CD8/PD-L1/PD-1 interaction compared to other TMIT subgroups. This evidence concerns the gene CD274 and neoplasm.